NANOREADY
LIVE

Serial Number

79402228

Owner

Samyang Holdings Corporation

Attorney

Richard Y. Kim

Filing Date

Jun 7, 2024

Add to watchlist:

No watchlists yet
View on USPTO

NANOREADY Trademark

Serial Number: 79402228 • Registration: 7772914

NANOREADY is a trademark filed by Samyang Holdings Corporation on June 7, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Samyang Holdings Corporation

31, Jong-ro 33-gil, Jongno-gu

Entity Type: 03

SAMYANG BIOPHARM CORPORATION

295, Pangyo-ro, Bundang-gu,

Entity Type: 98

Trademark Details

Filing Date

June 7, 2024

Registration Date

April 29, 2025

Published for Opposition

March 11, 2025

Goods & Services

Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; preservation of pharmaceuticals; custom manufacture of pharmaceuticals; destruction of medical waste; custom manufacture of medical devices for others; custom assembling of electronic components for medical devices; recycling of medical waste; processing of pharmaceuticals being custom manufacture of pharmaceuticals; manufacture of custom dental bridges for others; custom manufacture of dental prosthesis and dentures; processing and treatment of chemical reagents

Research and development of vaccines and medicines; biological information check, namely, genetic testing for medical research purposes; pharmaceutical research services; inspection of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; services for assessing the efficiency of pharmaceuticals, namely, product quality testing services; technological and scientific remote monitoring services relating to medical diagnostic devices, namely, remote monitoring of medical diagnostic systems for quality control purposes; medical research laboratories; providing computer software technical support services, namely, troubleshooting of computer software problems in the field of medical diagnostics; providing technological support services regarding medical diagnostic instruments, namely, troubleshooting of computer software problems; scientific research relating to medicines; analysis and evaluation of medical product development; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; providing information on the testing, inspection and scientific research of medical products; consultancy in the field of testing, inspection, and scientific research of medical products; blood testing for scientific medical research purposes; engineering services in the field of medical technology

Surgical gloves; surgical apparatus and instruments for veterinary use; veterinary apparatus, namely, electrocardiographs, X-ray apparatus, ultrasound apparatus and medical imaging apparatus for veterinary purposes; surgical instruments for use in general surgery; surgical sutures; surgical apparatus and instruments for medical, dental or veterinary use; medical instruments for use in general surgery; medical apparatus, namely medical radiation apparatus, medical X-ray apparatus, and medical imaging apparatus; medical instruments, namely medical hearing instruments; sanitary masks for medical use; cold-hot massage apparatus for medical use; suture materials for medical use; surgical apparatus and instruments for medical use; thread for medical use; protective face masks for medical use; gloves for medical purposes; medical apparatus, namely, medical apparatus for detecting cancer, medical imaging apparatus, ultrasonic medical diagnostic apparatus; apparatus for drug administration, namely, infusion and injection devices for administering drugs; syringes for injection of medical substances; orthopedic articles, namely, orthopedic belts, orthopedic soles, orthopedic footwear, orthopedic bandages, orthopedic bandages for joints and orthopaedic hosiery, and orthopedic apparatus and instruments for diagnostic and therapeutic use; dental instruments, namely root canal therapy instruments used to shave the inside of a root canal, dental root files used in root canal therapy procedures, reusable and recyclable prophy angles, prophy angles, disposable prophy angles, oral irrigators, hemostats that clamp blood vessels to diminish or halt blood flow, crown and bridge removers

Pharmaceutical preparations for health care, in particular for the prevention and treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases and for use in genetic therapy for the prevention and treatment of genetic disorders; medicine cases, portable, filled, in the nature of first-aid kits; vaccines; food supplements; vitamin and mineral dietary supplements; veterinary substances and preparations for the prevention and treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases and for use in genetic therapy for the prevention and treatment of genetic disorders; medicinal preparations for the mouth in the form of drops, capsules, tablets, or compressed tablets for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases, infectious diseases, and genetic disorders; ointments for pharmaceutical purposes for the treatment of pain, inflammation and skin disorders; cachets for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases, infectious diseases, and genetic disorders; pharmaceutical preparations being adrenal, parathyroid, pituitary, pancreas, and salivary gland hormone preparations for human use; ferments for pharmaceutical purposes; pre-moistened medicated tissues; pharmaceutical preparations, namely, elixirs for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases, infectious diseases, and genetic disorders; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases, infectious diseases, and genetic disorders; pharmaceutical drugs, namely, pharmaceutical preparations for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases, infectious diseases, and genetic disorders; human vaccine preparations; medicines for human purposes, namely, pharmaceutical preparations for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases, infectious diseases, and genetic disorders; pharmaceutical preparations for the treatment of cancer; nutraceutical preparations for therapeutic or medical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases, infectious diseases, and genetic disorders; antibiotics; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules sold empty and tablets that provide controlled release of the active ingredients that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of coatings for tablets that facilitate the delivery of nutritional supplements

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jun 4, 2026 NREP
CHANGE OF OWNER RECEIVED FROM IB
Feb 19, 2026 CHLD
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 29, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 14, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 14, 2026 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 11, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 23, 2025 FICS
FINAL DISPOSITION PROCESSED
Nov 23, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 30, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 29, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 29, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 18, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 13, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 13, 2025 TROA
REFUSAL PROCESSED BY IB
Feb 1, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 10, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jan 10, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 19, 2024 RFCR
NON-FINAL ACTION WRITTEN
Dec 18, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 17, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 21, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 21, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 15, 2024 REPR